Crovalimab
Chugai Pharmaceutical
['rova,(-approval),(-microvascular)', 'rova,(-approval)']
#crovalimab, a novel anti-c5 recycling monoclonal antibody, has received breakthrough therapy designation and priority review in #china. #ash22 #ash2022 #news #media
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma